Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

New medications could improve treatment for severe alopecia areata in Australia.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Keratinocytes contribute to hidradenitis suppurativa by causing inflammation and worsening the condition.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

New drug delivery systems show promise in effectively treating pathological scars.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

Both microneedling and injections are equally effective for treating alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Similar treatments might work for different types of scarring hair loss.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Alopecia areata may be linked to heart issues.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Dog skin with hair loss, when transplanted to mice, regrew hair, suggesting the hair loss cause is likely body-wide, not skin-specific.